[1] Saeedi P, Petersohn I, Salpea P, et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes Res Clin Pract, 2019; 157, 107843. doi:  10.1016/j.diabres.2019.107843
[2] Krinock MJ, Singhal NS. Diabetes, stroke, and neuroresilience: looking beyond hyperglycemia. Ann NY Acad Sci, 2021; 1495, 78−98. doi:  10.1111/nyas.14583
[3] Shukla V, Shakya AK, Perez-Pinzon MA, et al. Cerebral ischemic damage in diabetes: an inflammatory perspective. J Neuroinflammation, 2017; 14, 21. doi:  10.1186/s12974-016-0774-5
[4] Mi DH, Wang PL, Yang B, et al. Correlation of hyperglycemia with mortality after acute ischemic stroke. Ther Adv Neurol Disord, 2017; 11, 1756285617731686.
[5] Tuttolomondo A, Pinto A, Salemi G, et al. Diabetic and non-diabetic subjects with ischemic stroke: differences, subtype distribution and outcome. Nutr Metab Cardiovasc Dis, 2008; 18, 152−7. doi:  10.1016/j.numecd.2007.02.003
[6] Chen R, Ovbiagele B, Feng WW. Diabetes and stroke: epidemiology, pathophysiology, pharmaceuticals and outcomes. Am J Med Sci, 2016; 351, 380−6. doi:  10.1016/j.amjms.2016.01.011
[7] Quagliaro L, Piconi L, Assaloni R, et al. Intermittent high glucose enhances apoptosis related to oxidative stress in human umbilical vein endothelial cells: the role of protein kinase C and NAD(P)H-oxidase activation. Diabetes, 2003; 52, 2795−804. doi:  10.2337/diabetes.52.11.2795
[8] Shah AD, Langenberg C, Rapsomaniki E, et al. Type 2 diabetes and incidence of cardiovascular diseases: a cohort study in 1.9 million people. Lancet Diabetes Endocrinol, 2015; 3, 105−13. doi:  10.1016/S2213-8587(14)70219-0
[9] Kuroda J, Matsuo R, Yamaguchi Y, et al. Poor glycemic control and posterior circulation ischemic stroke. Neurol Clin Pract, 2019; 9, 129−39. doi:  10.1212/CPJ.0000000000000608
[10] Rao Kondapally Seshasai S, Kaptoge S, Thompson A, et al. Diabetes mellitus, fasting glucose, and risk of cause-specific death. N Engl J Med, 2011; 364, 829−41. doi:  10.1056/NEJMoa1008862
[11] Wada S, Yoshimura S, Inoue M, et al. Outcome prediction in acute stroke patients by continuous glucose monitoring. J Am Heart Assoc, 2018; 7, e008744. doi:  10.1161/JAHA.118.008744
[12] Liu FC, Yang XL, Li JX, et al. Association of fasting glucose levels with incident atherosclerotic cardiovascular disease: an 8-year follow-up study in a Chinese population. J Diabetes, 2017; 9, 14−23. doi:  10.1111/1753-0407.12380
[13] Mongraw-Chaffin M, LaCroix AZ, Sears DD, et al. A prospective study of low fasting glucose with cardiovascular disease events and all-cause mortality: the women's health initiative. Metabolism, 2017; 70, 116−24. doi:  10.1016/j.metabol.2017.02.010
[14] Wang C, Yuan Y, Zheng MY, et al. Association of age of onset of hypertension with cardiovascular diseases and mortality. J Am Coll Cardiol, 2020; 75, 2921−30.
[15] Wu SL, Song YJ, Chen SH, et al. Blood pressure classification of 2017 associated with cardiovascular disease and mortality in young Chinese adults. Hypertension, 2020; 76, 251−8. doi:  10.1161/HYPERTENSIONAHA.119.14239
[16] Zhang Q, Zhou Y, Gao X, et al. Ideal cardiovascular health metrics and the risks of ischemic and intracerebral hemorrhagic stroke. Stroke, 2013; 44, 2451−6. doi:  10.1161/STROKEAHA.113.678839
[17] Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA, 2001; 285, 2486−97. doi:  10.1001/jama.285.19.2486
[18] Saver JL. Proposal for a universal definition of cerebral infarction. Stroke, 2008; 39, 3110−5. doi:  10.1161/STROKEAHA.108.518415
[19] Jones BL, Nagin DS, Roeder K. A SAS procedure based on mixture models for estimating developmental trajectories. Sociol Methods Res, 2001; 29, 374−93. doi:  10.1177/0049124101029003005
[20] Nagin DS, Odgers CL. Group-based trajectory modeling in clinical research. Annu Rev Clin Psychol, 2010; 6, 109−38. doi:  10.1146/annurev.clinpsy.121208.131413
[21] Ashburner JM, Go AS, Chang Y, et al. Effect of diabetes and glycemic control on ischemic stroke risk in AF patients: ATRIA study. J Am Coll Cardiol, 2016; 67, 239−47.
[22] Robson R, Lacey AS, Luzio SD, et al. HbA1c measurement and relationship to incident stroke. Diabet Med, 2016; 33, 459−62. doi:  10.1111/dme.13057
[23] Selvin E, Coresh J, Shahar E, et al. Glycaemia (haemoglobin A1c) and incident ischaemic stroke: the Atherosclerosis Risk in Communities (ARIC) study. Lancet Neurol, 2005; 4, 821−6. doi:  10.1016/S1474-4422(05)70227-1
[24] Zabala A, Darsalia V, Holzmann MJ, et al. Risk of first stroke in people with type 2 diabetes and its relation to glycaemic control: A nationwide observational study. Diabetes Obes Metab, 2020; 22, 182−90. doi:  10.1111/dom.13885
[25] Jin C, Chen SH, Vaidya A, et al. Longitudinal change in fasting blood glucose and myocardial infarction risk in a population without diabetes. Diabetes Care, 2017; 40, 1565−72. doi:  10.2337/dc17-0610
[26] Zhang HN, Liu J, Qu D, et al. Serum exosomes mediate delivery of arginase 1 as a novel mechanism for endothelial dysfunction in diabetes. Proc Natl Acad Sci USA, 2018; 115, E6927−36.
[27] Dai XZ, Yan XQ, Zeng J, et al. Elevating CXCR7 improves angiogenic function of EPCs via Akt/GSK-3β/Fyn-mediated Nrf2 activation in diabetic limb ischemia. Circ Res, 2017; 120, e7−23.
[28] Palasubramaniam J, Wang XW, Peter K. Myocardial infarction-from atherosclerosis to thrombosis. Arterioscler Thromb Vasc Biol, 2019; 39, e176−85.
[29] Banerjee C, Chimowitz MI. Stroke caused by atherosclerosis of the major intracranial arteries. Circ Res, 2017; 120, 502−13. doi:  10.1161/CIRCRESAHA.116.308441
[30] Ceriello A, Esposito K, Piconi L, et al. Oscillating glucose is more deleterious to endothelial function and oxidative stress than mean glucose in normal and type 2 diabetic patients. Diabetes, 2008; 57, 1349−54. doi:  10.2337/db08-0063
[31] Caso V, Paciaroni M, Agnelli G, et al. Gender differences in patients with acute ischemic stroke. Womens Health (Lond), 2010; 6, 51−7. doi:  10.2217/WHE.09.82
[32] Divoky L, Maran A, Ramu B. Gender differences in ischemic cardiomyopathy. Curr Atheroscler Rep, 2018; 20, 50. doi:  10.1007/s11883-018-0750-x
[33] Yao MF, He J, Sun X, et al. Gender differences in risks of coronary heart disease and stroke in patients with type 2 diabetes mellitus and their association with metabolic syndrome in China. Int J Endocrinol, 2016; 2016, 8483405.